Zkusit zdarma
Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc.

TARS
Cena:
$ 62.26
-1.22 (-1.92%)
Valuace
100
Růst
23
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Tarsus Q1 Review: Strong Earnings, But Wall Street Wanted A Guidance Raise

Tarsus Q1 Review: Strong Earnings, But Wall Street Wanted A Guidance Raise

10:43 15-05-2026

Tarsus Pharmaceuticals (TARS) is reiterated as a Strong Buy, with a 12-month price target of $95 per...

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans

8:30 14-05-2026

IRVINE, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today a...

Tarsus Pharmaceuticals, Inc. (TARS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Tarsus Pharmaceuticals, Inc. (TARS) Presents at Bank of America Global Healthcare Conference 2026 Transcript

21:20 12-05-2026

Tarsus Pharmaceuticals, Inc. (TARS) Presents at Bank of America Global Healthcare Conference 2026 Tr...

Tarsus to Participate in Upcoming Investor Conferences

Tarsus to Participate in Upcoming Investor Conferences

17:00 07-05-2026

IRVINE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today ...

Tarsus Pharmaceuticals, Inc. (TARS) Q1 2026 Earnings Call Transcript

Tarsus Pharmaceuticals, Inc. (TARS) Q1 2026 Earnings Call Transcript

21:41 06-05-2026

Tarsus Pharmaceuticals, Inc. (TARS) Q1 2026 Earnings Call Transcript...

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Beats Revenue Estimates

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Beats Revenue Estimates

19:31 06-05-2026

Tarsus Pharmaceuticals, Inc. (TARS) came out with a quarterly loss of $0.16 per share versus the Zac...

Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements

Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements

16:05 06-05-2026

Generated first quarter XDEMVY ® net product sales of more than $145 million, an increase of more t...

Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026

Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026

16:30 29-04-2026

IRVINE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), toda...

Calamos Advisors LLC Makes New $2.82 Million Investment in Tarsus Pharmaceuticals, Inc. $TARS

Calamos Advisors LLC Makes New $2.82 Million Investment in Tarsus Pharmaceuticals, Inc. $TARS

4:56 27-04-2026

Calamos Advisors LLC purchased a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ: TAR...

Tarsus Pharmaceuticals: Marketing Spend Bears Fruit, Pipeline Progresses

Tarsus Pharmaceuticals: Marketing Spend Bears Fruit, Pipeline Progresses

1:44 14-04-2026

Tarsus Pharmaceuticals has performed an aggressive marketing push for Xdemvy in Demodex blepharitis,...

Capricorn Fund Managers Ltd Decreases Position in Tarsus Pharmaceuticals, Inc. $TARS

Capricorn Fund Managers Ltd Decreases Position in Tarsus Pharmaceuticals, Inc. $TARS

4:45 06-04-2026

Capricorn Fund Managers Ltd lessened its position in Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) by ...

Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease

Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease

8:30 31-03-2026

IRVINE, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today...

Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade

Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade

13:06 24-03-2026

An executive at Tarsus Pharmaceuticals sold 12,274 shares for a transaction value of approximately $...

TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus

TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus

8:30 23-03-2026

IRVINE, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today...

Tarsus Pharmaceuticals (NASDAQ:TARS) General Counsel Sells $283,428.75 in Stock

Tarsus Pharmaceuticals (NASDAQ:TARS) General Counsel Sells $283,428.75 in Stock

5:06 22-03-2026

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS - Get Free Report) General Counsel Bryan Wahl sold 4,125 ...

Insider Selling: Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells $279,658.00 in Stock

Insider Selling: Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells $279,658.00 in Stock

5:06 22-03-2026

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS - Get Free Report) insider Dianne Whitfield sold 4,174 sh...

Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells $279,718.41 in Stock

Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells $279,718.41 in Stock

5:06 22-03-2026

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS - Get Free Report) insider Dianne Whitfield sold 4,071 sh...

Insider Selling: Tarsus Pharmaceuticals (NASDAQ:TARS) General Counsel Sells $283,511.28 in Stock

Insider Selling: Tarsus Pharmaceuticals (NASDAQ:TARS) General Counsel Sells $283,511.28 in Stock

5:06 22-03-2026

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS - Get Free Report) General Counsel Bryan Wahl sold 4,084 ...

Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells $279,693.18 in Stock

Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells $279,693.18 in Stock

5:06 22-03-2026

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS - Get Free Report) insider Dianne Whitfield sold 4,029 sh...

Tarsus Pharmaceuticals (NASDAQ:TARS) General Counsel Sells $283,477.00 in Stock

Tarsus Pharmaceuticals (NASDAQ:TARS) General Counsel Sells $283,477.00 in Stock

5:06 22-03-2026

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS - Get Free Report) General Counsel Bryan Wahl sold 4,231 ...

close

TARSUS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND RECENT BUSINESS ACHIEVEMENTS

04-11-2025
DELIVERED QUARTERLY  XDEMVY ® NET SALES OF APPROXIMATELY $119 MILLION, UP APPROXIMATELY 147% YEAR-...
Více zde

TARSUS TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS ON TUESDAY, NOVEMBER 4, 2025

28-10-2025
IRVINE, CALIF., OCT. 28, 2025 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), TODAY...
Více zde

TARSUS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

27-08-2025
IRVINE, CALIF., AUG. 27, 2025 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), TODAY...
Více zde

TARSUS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND RECENT BUSINESS ACHIEVEMENTS

06-08-2025
RECORD QUARTERLY NET PRODUCT SALES OF $102.7 MILLION ACHIEVED WITHIN TWO YEARS OF OUR XDEMVY ® LAU...
Více zde

TARSUS TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS ON WEDNESDAY, AUGUST 6, 2025

30-07-2025
IRVINE, CALIF., JULY 30, 2025 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), TODAY...
Více zde

TARSUS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

29-05-2025
IRVINE, CALIF., MAY 29, 2025 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), TODAY ...
Více zde

TARSUS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

08-05-2025
IRVINE, CALIF., MAY 08, 2025 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS) TODAY A...
Více zde

ELANCO SELLS ROYALTY AND MILESTONE RIGHTS FOR LOTILANER IN HUMAN HEALTH TO BLACKSTONE; ACCELERATES DEBT PAYDOWN

05-05-2025
GREENFIELD, IND. , MAY 5, 2025 /PRNEWSWIRE/ -- ELANCO ANIMAL HEALTH INCORPORATED (NYSE: ELAN) TODAY ...
Více zde

TARSUS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND RECENT BUSINESS ACHIEVEMENTS

01-05-2025
GENERATED $78.3 MILLION IN NET PRODUCT SALES OF XDEMVY ® , AN INCREASE OF 217% YEAR OVER YEAR AND 1...
Více zde

TARSUS TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS ON THURSDAY, MAY 1, 2025

24-04-2025
IRVINE, CALIF., APRIL 24, 2025 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), TODA...
Více zde

TARSUS TO PRESENT SEVERAL SCIENTIFIC ABSTRACTS HIGHLIGHTING THE GLOBAL PREVALENCE OF DEMODEX BLEPHARITIS AND THE CLINICAL IMPACT OF XDEMVY AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY (ASCRS) 2025 ANNUAL MEETING

22-04-2025
IRVINE, CALIF., APRIL 22, 2025 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS) WILL ...
Více zde

TARSUS ANNOUNCES PRICING OF UPSIZED $125.0 MILLION PUBLIC OFFERING

12-03-2025
IRVINE, CALIF., MARCH 12, 2025 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS) (THE ...
Více zde

TARSUS ANNOUNCES PROPOSED $100.0 MILLION PUBLIC OFFERING

12-03-2025
IRVINE, CALIF., MARCH 12, 2025 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS) (THE ...
Více zde

TARSUS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCE

06-03-2025
IRVINE, CALIF., MARCH 06, 2025 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), TODA...
Více zde

TARSUS TO REPORT FOURTH QUARTER AND FULL-YEAR 2024 FINANCIAL RESULTS ON TUESDAY, FEBRUARY 25, 2025

20-02-2025
IRVINE, CALIF., FEB. 20, 2025 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), TODAY...
Více zde

TARSUS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

30-01-2025
IRVINE, CALIF., JAN. 30, 2025 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), TODAY...
Více zde

TARSUS PROVIDES 2025 UPDATE: ACCELERATING THE LAUNCH OF XDEMVY® AND ESTABLISHING OCULAR ROSACEA AS THE NEXT CATEGORY-CREATING OPPORTUNITY IN EYE CARE

13-01-2025
ADVANCING TP-04 (LOTILANER OPHTHALMIC GEL) FOR THE POTENTIAL TREATMENT OF OCULAR ROSACEA, ANOTHER LA...
Více zde

TARSUS WELCOMES KATE GOODRICH, M.D., MHS, TO ITS BOARD OF DIRECTORS

13-11-2024
HUMANA CMO BRINGS MORE THAN TWO DECADES OF EXPERIENCE DRIVING INNOVATIVE, VALUE-BASED INITIATIVES DE...
Více zde

TARSUS TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON WEDNESDAY, NOVEMBER 13, 2024

06-11-2024
IRVINE, CALIF., NOV. 06, 2024 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), WHOSE...
Více zde

TARSUS APPOINTS ELIZABETH YEU, M.D., AS CHIEF MEDICAL OFFICER

05-11-2024
DR. YEU TRANSITIONS FROM HER ROLE AS CHIEF MEDICAL ADVISOR AND BOARD MEMBER TO LEAD THE COMPANY'S NE...
Více zde

TARSUS LAUNCHES “YOUR MITEY PROBLEM,” THE FIRST DIRECT-TO-CONSUMER TV CAMPAIGN FOR XDEMVY® (LOTILANER OPHTHALMIC SOLUTION) 0.25%

17-10-2024
CAMPAIGN SHOWCASES ROOT CAUSE OF DEMODEX BLEPHARITIS THROUGH CREATIVE REPRESENTATION OF MISCHIEF-CAU...
Více zde

TARSUS TO PARTICIPATE IN FIRESIDE CHAT AT UBS VIRTUAL OPHTHALMOLOGY DAY 2024

25-09-2024
IRVINE, CALIF., SEPT. 25, 2024 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), WHOS...
Více zde

TARSUS TO PARTICIPATE IN FIRESIDE CHAT AT THE 2024 WELLS FARGO SECURITIES HEALTHCARE CONFERENCE

28-08-2024
IRVINE, CALIF., AUG. 28, 2024 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), WHOSE...
Více zde

TARSUS TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON THURSDAY, AUGUST 8, 2024

29-07-2024
IRVINE, CALIF., JULY 29, 2024 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), WHOSE...
Více zde

TARSUS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

29-05-2024
IRVINE, CALIF., MAY 29, 2024 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), WHOSE ...
Více zde

TARSUS TO PARTICIPATE IN FIRESIDE CHAT AT THE 2024 BANK OF AMERICA HEALTHCARE CONFERENCE

09-05-2024
IRVINE, CALIF., MAY 09, 2024 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), WHOSE ...
Více zde

TARSUS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND RECENT BUSINESS ACHIEVEMENTS

08-05-2024
GENERATED $24.7 MILLION IN NET PRODUCT SALES OF XDEMVY ® , AN 89% INCREASE OVER Q4 2023, AND DELIVE...
Více zde

TARSUS TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON WEDNESDAY, MAY 8, 2024

01-05-2024
IRVINE, CALIF., MAY 01, 2024 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), WHOSE ...
Více zde

TARSUS STRENGTHENS FINANCIAL POSITION AND REFINANCES EXISTING DEBT WITH $200 MILLION NON-DILUTIVE FINANCING COMMITMENT FROM PHARMAKON

23-04-2024
IRVINE, CALIF., APRIL 23, 2024 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), WHOS...
Více zde

TARSUS TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES

05-03-2024
IRVINE, CALIF., MARCH 05, 2024 (GLOBE NEWSWIRE) -- TARSUS PHARMACEUTICALS, INC. (NASDAQ: TARS), WHOS...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-12 00:00:008-KStáhnout
2025-11-04 00:00:008-KStáhnout
2025-11-04 00:00:0010-QStáhnout
2025-08-06 01:00:008-KStáhnout
2025-08-06 01:00:0010-QStáhnout
2025-08-06 00:00:008-KStáhnout
2025-08-06 00:00:0010-QStáhnout
2025-06-18 01:00:008-KStáhnout
2025-06-18 00:00:008-KStáhnout
2025-05-01 01:00:008-KStáhnout
2025-05-01 01:00:0010-QStáhnout
2025-05-01 00:00:008-KStáhnout
2025-05-01 00:00:0010-QStáhnout
2025-03-18 00:00:008-KStáhnout
2025-03-17 23:00:008-KStáhnout
2025-03-13 00:00:008-KStáhnout
2025-03-12 23:00:008-KStáhnout
2025-02-25 00:00:008-KStáhnout
2025-02-25 00:00:0010-KStáhnout
2025-02-24 23:00:008-KStáhnout
2025-02-24 23:00:0010-KStáhnout
2025-01-17 00:00:008-KStáhnout
2025-01-16 23:00:008-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-12-19 00:00:008-KStáhnout
2024-12-18 23:00:008-KStáhnout
2024-11-13 00:00:008-KStáhnout
2024-11-13 00:00:0010-QStáhnout
2024-11-12 23:00:008-KStáhnout
2024-11-12 23:00:0010-QStáhnout
2024-11-05 00:00:008-KStáhnout
2024-11-04 23:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-06-18 01:00:008-KStáhnout
2024-06-18 00:00:008-KStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:008-KStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-04-23 01:00:008-KStáhnout
2024-04-23 00:00:008-KStáhnout
2024-03-05 00:00:008-KStáhnout
2024-03-04 23:00:008-KStáhnout
2024-03-01 00:00:008-KStáhnout
2024-02-29 23:00:008-KStáhnout
2024-02-27 00:00:008-KStáhnout
2024-02-27 00:00:0010-KStáhnout
2024-02-26 23:00:008-KStáhnout
2024-02-26 23:00:0010-KStáhnout
2024-01-18 00:00:008-KStáhnout
2024-01-17 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-12-11 00:00:008-KStáhnout
2023-12-10 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-08-10 01:00:008-KStáhnout
2023-08-10 01:00:0010-QStáhnout
2023-08-10 00:00:008-KStáhnout
2023-08-10 00:00:0010-QStáhnout
2023-08-02 01:00:008-KStáhnout
2023-08-02 00:00:008-KStáhnout
2023-07-31 01:00:008-KStáhnout
2023-07-31 00:00:008-KStáhnout
2023-07-25 01:00:008-KStáhnout
2023-07-25 00:00:008-KStáhnout
2023-06-27 01:00:008-KStáhnout
2023-06-27 00:00:008-KStáhnout
2023-06-15 01:00:008-KStáhnout
2023-06-15 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-04-24 01:00:008-KStáhnout
2023-04-24 00:00:008-KStáhnout
2023-03-17 00:00:0010-KStáhnout
2023-03-16 23:00:0010-KStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-12 23:00:008-KStáhnout
2023-01-05 00:00:008-KStáhnout
2023-01-04 23:00:008-KStáhnout
2022-12-07 00:00:008-KStáhnout
2022-12-06 23:00:008-KStáhnout
2022-11-09 00:00:008-KStáhnout
2022-11-09 00:00:0010-QStáhnout
2022-11-08 23:00:008-KStáhnout
2022-11-08 23:00:0010-QStáhnout
2022-10-12 01:00:008-KStáhnout
2022-10-12 00:00:008-KStáhnout
2022-08-11 01:00:008-KStáhnout
2022-08-11 01:00:0010-QStáhnout
2022-08-11 00:00:008-KStáhnout
2022-08-11 00:00:0010-QStáhnout
2022-06-22 01:00:008-KStáhnout
2022-06-22 00:00:008-KStáhnout
2022-05-11 01:00:0010-QStáhnout
2022-05-11 00:00:0010-QStáhnout
2022-05-10 01:00:008-KStáhnout
2022-05-10 00:00:008-KStáhnout
2022-05-04 01:00:008-KStáhnout
2022-05-04 00:00:008-KStáhnout
2022-05-03 01:00:008-KStáhnout
2022-05-03 00:00:008-KStáhnout
2022-05-02 01:00:008-KStáhnout
2022-05-02 00:00:008-KStáhnout
2022-03-14 00:00:008-KStáhnout
2022-03-14 00:00:0010-KStáhnout
2022-03-13 23:00:008-KStáhnout
2022-03-13 23:00:0010-KStáhnout
2022-02-02 00:00:008-KStáhnout
2022-02-01 23:00:008-KStáhnout
2022-01-04 00:00:008-KStáhnout
2022-01-03 23:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-01 00:00:008-KStáhnout
2021-10-31 23:00:008-KStáhnout
2021-08-12 01:00:008-KStáhnout
2021-08-12 00:00:008-KStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 01:00:0010-QStáhnout
2021-08-05 00:00:008-KStáhnout
2021-08-05 00:00:0010-QStáhnout
2021-06-22 01:00:008-KStáhnout
2021-06-22 00:00:008-KStáhnout
2021-06-21 01:00:008-KStáhnout
2021-06-21 00:00:008-KStáhnout
2021-05-11 01:00:008-KStáhnout
2021-05-11 01:00:0010-QStáhnout
2021-05-11 00:00:008-KStáhnout
2021-05-11 00:00:0010-QStáhnout
2021-04-09 01:00:008-KStáhnout
2021-04-09 00:00:008-KStáhnout
2021-03-31 01:00:008-KStáhnout
2021-03-31 01:00:0010-KStáhnout
2021-03-31 00:00:008-KStáhnout
2021-03-31 00:00:0010-KStáhnout
2021-03-30 01:00:008-KStáhnout
2021-03-30 00:00:008-KStáhnout
2020-11-25 00:00:0010-QStáhnout
2020-11-24 23:00:0010-QStáhnout
2020-11-20 00:00:008-KStáhnout
2020-11-19 23:00:008-KStáhnout
2020-11-17 00:00:008-KStáhnout
2020-11-16 23:00:008-KStáhnout
2020-10-20 01:00:008-KStáhnout
2020-10-20 00:00:008-KStáhnout
preloader